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Abstract 7 
 8 
AIM: To compare the use and provision of analgesia to cats undergoing gonadectomy by a 9 
sample of veterinarians in New Zealand, Australia and the United Kingdom.  10 
METHODS: Small animal veterinarians’ views and practices on provision of analgesia to 11 
cats at three different time phases (pre/intra-operatively, post-operatively and post-discharge) 12 
were gathered using an electronic questionnaire. Respondents were also asked to state the 13 
pharmacological agent(s) used and the dosage rate(s). Differences in provision of analgesia 14 
were assessed relative to the respondent using binary logistic regression. The effects of sex of 15 
the patient and time of provision were explored using McNewar’s Test and Cochran’s Q 16 
respectively. Differences between drug types used amongst countries was tested using a 17 
cross-tabulation.  18 
RESULTS: There were 717 responses to the survey. Of these 249 (34.7%) were from New 19 
Zealand, 269 (37.5%) were from the UK and 199 (27.8%) from Australia. The prevalence of 20 
analgesia provision declined across the three different time phases for spaying and castration 21 
(both p<0.001). Provision of analgesia for castration was less than for spaying at each of the 22 
pre/intra-operative (p=0.002), post-operative (p<0.001) and after discharge (p<0.001) phases.   23 
Post-operative provision of analgesia following both castration (p<0.001) and spaying 24 
(p<0.001) differed amongst countries of practice. Veterinarians in Australia and New Zealand 25 
2 
were more likely to provide post-operative analgesia for both castration and spaying than 26 
those from the UK (p<0.001). Veterinarians from the UK more commonly used non-steroidal 27 
anti-inflammatory drugs (NSAID) in the pre/intra-operative phase (p<0.001) than 28 
veterinarians from either New Zealand or Australia. 29 
CONCLUSIONS AND CLINICAL RELEVANCE: Contemporary use of analgesics for cats 30 
appears focused on provision at clinic and may not address the effects of surgery beyond the 31 
first 24 hours. The UK, Australia and New Zealand clearly differ in the types of analgesia 32 
administered, possibly reflecting differing professional considerations of the risks associated 33 
with the use of NSAID. In the interests of animal welfare, pain relief should perhaps be 34 
provided or offered more frequently for owner administration.  35 
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Abbreviations 37 
 38 
ASAVA  Australian Small Animal Veterinary Association 39 
BSAVA British Small Animal Veterinary Association 40 
BVA   British Veterinary Association 41 
CAS   Companion Animal Society 42 
COX  Cyclooxygenase 43 
F  Female 44 
M  Male 45 
NSAID Non-steroidal Anti-inflammatory Drug(s) 46 
NZVA  New Zealand Veterinary Association 47 
UK  United Kingdom 48 
 49 
Introduction 50 
 51 
As the most common elective surgery for cats, gonadectomy is of legitimate interest both in 52 
terms of animal welfare and effective companion animal population management. Most 53 
owners that present cats at clinic for surgeries do so for elective procedures. Therefore the 54 
expectation is that these cats are free from pain prior to provision of veterinary care (Dyson 55 
2008). As such, pain in general and, more specifically, the pain associated with gonadectomy, 56 
require careful management. Failure to do so for such a common procedure may impose 57 
substantial welfare costs on the animals concerned.  58 
3 
The efficacy of pain management for cats is often elucidated through research which uses 59 
ovariohysterectomy as the surgical model (e.g. Al-Gizawy et al. 2004; Giordano et al. 2010; 60 
Cagnardi et al. 2011). Pain behaviours following gonadectomy have been found to persist for 61 
substantial lengths of time (Väisänen et al. 2007; Waran et al. 2007) but also diminish 62 
following provision of post-operative butorphanol (Rütgen et al. 2011). Despite this, 63 
analgesia for owner administration following discharge from the clinic has received little 64 
attention in the literature. It should be noted that Meloxicam is available as an oral analgesic 65 
and has been reported as commonly used “off-label” for treatment of pain in cats (Robertson, 66 
2005). Data concerning longitudinal provision of carprofen (Steagall et al. 2009) indicate that 67 
prolonged post-operative pain management for cats by their owners may be possible as long 68 
as there are no complicating factors (e.g. reduced renal function) and owners do not exceed 69 
the stated dose. 70 
In general analgesia provision is affected by the gender, time since graduation (Lascelles et 71 
al. 1999) and practice size (Raekallio et al. 2003) of the practitioner. Historically, research 72 
into provision of analgesia for cats during or following gonadectomy demonstrates it to be 73 
low, especially when compared to dogs (e.g. Williams et al. 2005). It is then, perhaps, 74 
unsurprising that analgesia for cats has been described as under-provisioned (Robertson, 75 
2005). In general, analgesia provision for castration is less common compared to 76 
ovariohysterectomy (Dohoo and Dohoo, 1996; Lascelles et al. 1999; Wright 2002; 77 
Hugonnard et al. 2004; Raekallio et al. 2003). In part this is due to the perceived differences 78 
in pain caused by the two procedures (Williams et al. 2005). This sex difference is also 79 
expressed through owner reports where male cats received a significantly lower pain severity 80 
score than female cats (Väisänen et al. 2007).  However, experimentally, this difference may 81 
become non-significant after 1.5 hours (Cagnardi et al. 2011).  82 
Overall, the literature suggests that under-provision of analgesia to cats arises from their 83 
unique physiology, a lack of approved NSAID for use in cats (Lascelles et al. 2007) and a 84 
general wariness amongst veterinary practitioners when using certain drug types. For 85 
example, the perception that opioids induce mania in cats persists (Robertson 2005), despite 86 
the fact that this only resulted from doses of 20mg/kg (Dhasmana et al. 1972). Similarly it is 87 
suggested that concern around the impact of non-steroidal anti-inflammatory drugs (NSAID) 88 
on renal function and integrity is evident amongst veterinarians, despite there being 89 
suggestion that this is mitigated if they are used correctly (Robertson and Taylor, 2004).  The 90 
pre-operative use of NSAID such as meloxicam and carprofen is reported as common 91 
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practice in the UK and, in healthy cats, renal side effects appear to be rare (Lascelles et al. 92 
2007). However, others suggest it should only be used post-operatively and after recovery 93 
from anaesthesia (Wright, 2002).  94 
The timing of administration of analgesia is also important as are the combinations of 95 
analgesic agents used. Similarly, it has been cited in other species that pre-emptive analgesia 96 
may attenuate the post-operative pain response. For example, Lascelles et al. (1997) 97 
identified that pre-emptive analgesia using pethidine reduced post-surgical hyperalgesia in 98 
dogs following ovariohysterectomy. In turn it is argued that this reduction in nociceptive 99 
input may function to reduce the requirements for analgesia post-operatively (Pascoe 2000; 100 
Wright 2002). Little research has been conducted that addresses pre-emptive analgesia 101 
provision and efficacy for cats specifically. 102 
Elective surgeries also result in pain with a number of root causes (e.g. inflammation and 103 
acute tissue injury). Processing of these different insults occurs through a variety of complex 104 
mechanisms. In terms of cats, there is little explicit evidence of the value and efficacy of 105 
multimodal analgesia in the literature (Lascelles et al. 2007) although it is anecdotally 106 
reported as commonly used, and efficacious, in a clinical setting (Robertson, 2005). In 107 
general, post-operative NSAID provide long periods of analgesia, for example Meloxicam 108 
may provide up to 24 hours of pain relief for cats (Robertson, 2005) whereas the opioid 109 
hydromorphone may only be effective for up to 5 hours (Wegner and Robertson, 2003). Post-110 
operative pain assessment following ovariohyseterctomy using carprofen, ketoprofen or 111 
meloxicam was found to provide appropriate analgesia for the majority of cats for up to 18 112 
hours (Slingsby and Waterman-Pearson, 2000). As such NSAID may be able to significantly 113 
reduce pain for the patient even after discharge from the clinic. The length of post-operative 114 
cover will depend on whether they are provided as part of the pre-medication, immediately 115 
following the operation or sometime after regaining consciousness.  116 
This paper sought to explore the current provision of analgesia to both male and female cats 117 
during and following gonadectomy. It is hypothesised that provision of analgesia will be 118 
contingent upon the sex of the patient and will be less likely as time since the operation 119 
increases. In addition, provision of analgesics is considered relative to the practitioner’s 120 
gender, time since graduation and country of practice, to establish any effects. We also 121 
hypothesise that analgesia provision may be affected by the characteristics of the 122 
veterinarian. Finally descriptions of the analgesics used are provided and discussed. 123 
5 
 124 
Materials and methods 125 
 126 
This study targeted companion animal veterinarians in New Zealand, Australia and the UK. 127 
A questionnaire containing 34 questions, taking approximately 10-15 minutes to complete 128 
(Supplementary Figure 1) was disseminated on-line (www.surveymonkey.com) through a 129 
direct link promoted by the New Zealand Veterinary Association’s Companion Animal 130 
Society (NZVA-CAS), the British Veterinary Association (BVA) and British Small Animal 131 
Veterinary Association (BSAVA) and the Australian Small Animal Veterinary Association 132 
(ASAVA). To improve response rates the associations and people responsible for promoting 133 
the survey were prompted to remind their members on two occasions during data collection.  134 
Only responses to 17 of the 34 questions are considered in this paper as the other questions 135 
related to practices and attitudes concerning implementation of pre-pubertal gonadectomy 136 
(Farnworth et al. 2013). Information gathered included, basic information about the 137 
respondent including gender, year of qualification and country of current practice. In addition 138 
respondents were asked about their provision of analgesia, including drugs and dosages used, 139 
for male and female cats during gonadectomy. Respondents were also asked about analgesia 140 
provision during three specific phases, these being: the intra/pre-operative phase, the post-141 
operative phase and post-discharge phase.  142 
 143 
Statistical analyses 144 
 145 
The data were described in terms of percentage of respondents providing a given answer as 146 
well as providing mean or median values and ranges where appropriate. Statistical analyses 147 
were conducted using the Statistical Package for the Social Sciences (SPSS) version 19.0 for 148 
Windows (IBMInc, Chicago IL, USA).  For the purposes of analysis graduation time was 149 
condensed into the categories 0-10, 11-20 and 21+ years. Statistical significance was 150 
established at p < 0.05. 151 
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McNemar’s test was to explore whether there were differences in the likelihood (yes or no) 152 
that analgesics were provided to male and female cats at three different time stages during 153 
gonadectomy, namely pre/intra-operatively, post-operatively and after discharge. We then 154 
used Cochran’s Q test to test for differences in the likelihood (yes or no) of pain relief 155 
provision among the three time phases for both males (castration) and females (spaying). We 156 
adjusted the significance levels, to account for the multiple tests, using a Bonferroni 157 
correction. 158 
Binary logistic regression was used to determine the possible impact of the main effects of 159 
gender of veterinarian, country of practice and graduation time category (0-10 years, 11-20 160 
years, and ≥20 years) on analgesia provision (yes or no) to cats undergoing gonadectomy.  161 
The possible effects of the two-way interaction between gender and graduation time and 162 
between gender and country of practice and the effect of the three-way interaction of gender, 163 
graduation time and country of practice were also examined.  We investigated this 164 
relationship separately for each combination of time phase and procedure (castration or spay). 165 
This avoided issues around independence of error within a single analysis due to repeat 166 
measure caused by multiple non-independant responses from each veterinarian   To 167 
accommodate the use of repeated tests on the same data set we adjusted our threshold 168 
significance level using the Bonferroni Correction. The adjusted significant level was 169 
calculated at p = 0.008. 170 
Finally data concerning the drugs used were tabulated to identify the number of practitioners 171 
using multimodal therapies. For the purposes of analysis drugs reported by respondents using 172 
trademarked names (e.g. Rimadyl) were re-categorised based on their generic active 173 
ingredient (e.g. carprofen). Following cross-tabulation we examined the association between 174 
the use of NSAID only, opioid only and opioid/NSAID combination drug regimens and 175 
country of practice using chi-square analyses. Other combinations are presented but were too 176 
infrequent to allow meaningful statistical analysis. In the analysis we controlled for procedure 177 
(castration or spaying). As for the previous analyses the association was tested separately for 178 
the two time phases namely the pre-/intra-operative and immediately post-operative periods. 179 
Significance levels were also subject to a Bonferroni adjustment with the new threshold level 180 
set at 0.025.  181 
 182 
Results 183 
7 
Basic demographics 184 
 185 
There were 717 responses to the survey. Of these 249 (34.7%) were from New Zealand, 269 186 
(37.5%) were from the UK and 199 (27.8%) from Australia. For New Zealand this response 187 
rate represents 41.6% of the total NZVA-CAS membership (249/599 ; S Blaikie,1 pers. 188 
comm.). The UK and Australian samples groups were less easily contacted and the 189 
percentage response rates for the UK (269/4500; 6%; T Sainty 2, pers. comm.) and Australia 190 
(199/1460; 13.6%; M Cole3, pers. comm.) are substantially lower than those for New 191 
Zealand. A greater percentage of females (F) responded (Australia 75%; New Zealand 58%; 192 
UK 66%) than males (M) when compared to the veterinary associations statistics which are 193 
as follows: ASAVA: F=49.2% M=50.8%; BVA: F=57.9% M=42.2%; NZVA-CAS F=49% 194 
M=51%.  195 
 196 
Differences in analgesia use relative to procedure and phase 197 
 198 
The likelihood that pain relief would be provided differed between male and female cats at 199 
each of the pre/intra-operative, post-operative and after discharge phases (p = 0.002; p < 200 
0.001; p <0.001 respectively). Similarly the likelihood of pain relief provision showed a 201 
significant decline across the pre, post- and after discharge periods for both male (Cochran’s 202 
Q = 803.55; df = 2; p < 0.001) and female (Cochran’s Q = 730.331; df = 2; p < 0.001) cats 203 
(see Table 1).  204 
 205 
Differences in analgesia provision amongst respondents 206 
 207 
Pre-operative analgesia 208 
                                                                        
1 S Blaikie, Secretary of NZVA-CAS, Kapiti Coast, New Zealand 
2 T Sainty, Head of Membership, BVA, 7 Mansfield Street. London, UK 
3 M Cole, Administration Officer, ASAVA, Unit 40, 6 Herbert Street, St. Leonards, New South Wales, Australia 
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A large majority of veterinarians in all combinations of categories (i.e. country, gender and 210 
graduation time) provide pain relief during the pre-operative stage of both castration and 211 
spaying respectively (Australia: 168/196 (85.7%) and 154/171 (90.1%); New Zealand 212 
227/245 (92.7%) and 213/225 (94.7%); UK 255/265 (96.2%) and 244/249 (98%)). 213 
Accordingly the number of responses to the category of “no provision of analgesia” was 214 
small or zero. Because of this incomplete information from predictors the statistical 215 
procedures associated with the logistic regression are inappropriate. We elected not conduct 216 
the analysis at this time phase.   217 
 218 
Post-operative analgesia for castration 219 
 220 
A test of the full model against a constant only model was statistically significant , indicting 221 
the inclusion of the  independent variables of gender, country of practice and graduation time 222 
significantly improved the chance of predicting category membership (i.e. whether or not 223 
pain provision was provided)  (χ2=84.482; df = 15; p < 0.001).  Examination of the main 224 
effects of gender, country of practice and graduation time individually revealed  that only the 225 
main effect of country of practice was significant (Wald statistic = 13.907; df = 2; p = 0.001) 226 
(see Table 2). The proportion of the variance accounted for by the regression model was 227 
relatively small at around 16 % (Nagelkerke R2 = 0.167).  228 
 229 
Expressed as an odds ratios, New Zealand veterinarians are 2.382 (95 % CI: 1.372-4.138) 230 
times more likely to provide post-operative analgesia after castration than UK veterinarians. 231 
The equivalent odds ratio for the Australia-United Kingdom comparison is 2.885 (95 % CI: 232 
1.510-5.512)    233 
 234 
Post-operative analgesia for spaying 235 
 236 
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A test of the full model against a constant only model was statistically significant , indicting 237 
the inclusion of the  independent variables of gender, country of practice and graduation time 238 
significantly improves on chance in predicting category membership (i.e. whether or not pain 239 
provision was provided)  (χ2=113.24; df = 15; p < 0.001). Individual examination of the main 240 
effects of gender, country of practice and graduation time revealed  that only the main effect 241 
of country of practice was significant (Wald statistic = 23.819; df = 2; p < 0.001) (see Table 242 
2). The proportion of the variance accounted for by the regression model was relatively small 243 
at around 22 % (Nagelkerke R2 = 0.223).  244 
 245 
Expressed as odds ratio New Zealand veterinarians are 4.038 (95 % CI: 2.199-7.412) times 246 
more likely to provide post-operative analgesia than UK veterinarians. The equivalents odds 247 
ratio for the Australia-United Kingdom comparison is 3.193 (95 % CI: 1.604-6.357)    248 
 249 
Provision of analgesia for owner administration  250 
 251 
A test of the full model against a constant only model was not statistically significant, 252 
indicting the inclusion of the independent variables of gender, country of practice and 253 
graduation time did not improve on chance in predicting category membership (i.e. whether 254 
or not pain provision was provided) for castration (χ2=12.507; df = 15; p = 0.640) or spaying 255 
(χ2=18.139; df = 15; p = 0.244). 256 
 257 
Analgesics used relative to country of practice 258 
 259 
When controlling for procedure (castration or spay), we demonstrated a significant 260 
association between country of practice and the drug regime (opioids only, NSAID only, 261 
combination of opioids and NSAID) for the pre/intra-operative time phase (Castration:  χ2 = 262 
171.521; df = 4; p < 0.001, Spay: χ2 = 191.853; df = 4; p < 0.001). The significant difference 263 
was driven by the higher likelihood that veterinarians in the United Kingdom would use 264 
NSAID only or in combination with opioids when compared to veterinarians from New 265 
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Zealand and Australia (Table 3). The differences in drug regime were less marked for the 266 
immediate post-operative period (Table 3). However there remained a similar significant 267 
association between country of practice and drug regime for castration (χ2 = 13.026; df = 4; p 268 
< 0.011) but not for spaying (χ2 = 8.161; df = 4; p = 0.086). The significant effect of country 269 
of practice on drug regime appeared largely driven by the relatively higher use of opioids for 270 
analgesia provision in New Zealand. 271 
Due to wide variations in the manner in which respondents reported the dosage used for each 272 
analgesic and a lack of information about how these were administered these data were 273 
excluded from further analysis. 274 
 275 
Discussion 276 
 277 
In this sample veterinary provision of analgesia for cats undergoing gonadectomy is 278 
substantial in the pre/intra-operative phase. It appears from comparison with earlier literature 279 
from Australia, New Zealand and the UK that routine provision of analgesia has increased in 280 
both the pre/intra-operative and post-operative phases (Watson et al. 1996; Lascelles et al. 281 
1999; Williams et al 2005). Some caution should be taken in interpretation of these findings 282 
given the different survey vehicles used and populations sampled. For example, Williams et 283 
al. (2005) specifically asked about peri-operative use of analgesia which could include some 284 
overlap between the pre/intra- and post-operative distinction used in this research. It also 285 
surveyed a larger sample of veterinarians and not just those that specialised in companion 286 
animal practice. Watson et al. (1996) were also not specifically companion animal focused 287 
and the use of analgesics for ovariohysterectomy of dogs and cats was reported as a 288 
combined percentage of 6% (Watson et al. 1996). It should also be noted that, as with any 289 
survey, the likelihood for non-response bias is substantial as those choosing not to answer the 290 
survey may represent a specific group (e.g. veterinarians that are not interested in analgesia). 291 
Even allowing for these distinctions, the authors are confident in their assertion that 292 
veterinarians are far more likely to use analgesia for cats in contemporary practice. 293 
In the pre/intra-operative phase the overall provision of analgesics to male and female cats is 294 
92.2% and 95% respectively. This suggests not only a change in the number of practitioners 295 
using analgesia but also greater equity of analgesia provision between the two procedures. 296 
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Previous reporting in the literature suggests that male veterinarians and those in practice for 297 
longer were less likely to provide analgesia (Lascelles et al. 1999). Our analyses indicate that 298 
although the category ‘time since graduation’ may explain some of the likelihood that 299 
analgesia is provided, the effects are trivial, country of practice explains the majority of any 300 
effect. Likewise no evidence for differences between male and female practitioners were 301 
found. These changes suggest an overall recognition of the importance of managing pain, 302 
both in practice and likely in veterinary education. The under-provisioning of analgesia for 303 
cats (Robertson, 2005), in these three countries and for this procedure at least, appears to be 304 
waning.  305 
Post-operative analgesia provision is also prevalent in the three countries surveyed indicating 306 
that the duration of pain management for cats undergoing gonadectomy is, for many, able to 307 
address issues of pain in the clinic. However, post-operative administration of drugs is not as 308 
common as pre/intra-operative management, particularly in the UK (Table 2). Improvements 309 
may still be able to be made. However it is important to note that those practitioners that 310 
provide pre/intra-operative NSAID should exercise caution. Post-operative overdosing of 311 
meloxicam (oral provision after previous parenteral dosing) has resulted in renal 312 
insufficiency in eight cats in the UK (Dyer et al. 2010).  313 
Also of note is the inequity between male and female cats, possibly reflecting the continued 314 
perception, rightly or otherwise, that castration is less painful that ovariohysterectomy 315 
(Wright, 2002). Anecdotally some respondents to the survey indicated that they would like to 316 
provide post-operative pain relief but that clients did not expect to pay extra for the 317 
medication and veterinary practices could not be expected to carry the financial burden. This 318 
raises an interesting dilemma for veterinary practices in terms of meeting the needs of the 319 
patient and the client (owner) as well as establishing exactly how much, and what period, of 320 
analgesia is appropriate for gonadectomy. Further research should investigate owner 321 
willingness to pay for analgesia and veterinary perception of obligation to provide analgesia 322 
following surgery. 323 
There was a general paucity of provision of post-discharge pain relief, 16.1% and 3.8% of 324 
respondents provided analgesia for clients to take home following spaying and castration 325 
respectively. Practitioners were not asked why they chose to provide, or not provide, 326 
analgesia. Possible reasons for non-provision of post-discharge analgesia may include 327 
concerns about longer term use of NSAID (Robertson, 2008; Dyer et al. 2010), a lack of 328 
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owner willingness to pay and a lack of awareness of practitioners as to the potential duration 329 
of pain caused by gonadectomy. A recent survey of pet owners’ expectations in Great Britain 330 
suggests that 61% of owners would expect their pet to be sent home with pain relief 331 
following surgery (Demetriou et al. 2009). The findings in this research suggest this 332 
expectation is not being met following gonadectomy. Further research on pain management 333 
following discharge, extending beyond gonadectomy of cats into a range of surgeries and 334 
species, may be useful. 335 
In the UK sample mean percentage report of pre/intra-operative NSAID across the two 336 
procedures (43.5%) is substantially more commonplace than in New Zealand (5.9%) and 337 
Australia (18%). Likewise, although the use of a combined NSAID and opioid pre/intra-338 
operative therapy is relatively uncommon, it is, on average, utilised more frequently by 339 
practitioners in the UK (24.4%) than those in New Zealand (2.3%) or Australia (9.7%). In 340 
part this may be associated with the length of time that NSAID have been commonly used 341 
pre/intra-operatively, although exactly how is hard to clarify. As previously cited there is still 342 
some controversy around the use of NSAID in general. Some authors argue that risk is 343 
minimal if the dose and anaesthetic regime are appropriate (e.g. Gurney, 2012) whilst others 344 
argue more strenuously for caution based on the potential risks (e.g. Wright, 2002). A 345 
comparison of Williams et al. (2005) with Lascelles et al. (1999) indicates that in New 346 
Zealand 93% of vets indicated concern about the side-effects associated with NSAID use, 347 
compared with only 75% in the UK some 6 years prior. It is not within the scope of this paper 348 
to argue for or against pre/intra-operative NSAID use or to dispute what is ‘reasonable 349 
caution’. However, as asserted by Lascelles et al. (2007), there is a clear need for more 350 
research which specifically addresses the value of single-mode and multi-modal NSAID 351 
therapies and multi-modal therapies in general (Robertson, 2008)  in the treatment and 352 
amelioration of pain in cats. An epidemiological study of NSAID linked mortality or lasting 353 
harm in otherwise problem-free cats may also be useful. 354 
Wider pre/intra-operative use of NSAID in the UK appears to reduce the likelihood that 355 
practitioners will provide further post-operative analgesia. Conversely practitioners in 356 
Australia and New Zealand show reduced usage of NSAID in the pre/intra-operative phase 357 
but more use of NSAID post-operatively. The use of NSAID is often promoted as, in general, 358 
it provides a far longer period of analgesia than commonly used opioids (Robertson, 2008). 359 
Therefore, later administration, or a post-operative boost, may serve to extend the period of 360 
pain relief. Many authors identify that pre-emptive pre/intra-operative use of analgesics, 361 
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including NSAID, could subsequently reduce the post-operative pain response, and hence the 362 
need for analgesia (e.g. Kelly et al. 2001). Additionally pre/intra-operative NSAID may also 363 
reduce post-operative inflammatory pain. It is reasonable then to pose the question: If limited 364 
NSAID analgesia is to be used is it better to provide it post-operatively to extend the period 365 
of analgesia (as in New Zealand and Australia), or earlier to avoid subsequent sensitisation 366 
and need for increased post-operative analgesia (as in the UK)? There is some research 367 
demonstrating the effect of central sensitisation in dogs (Lascelles et al. 1997, 1998; Welsh et 368 
al.1997), however currently there is none for cats. The authors recommend more research be 369 
undertaken in order to explore this question. 370 
It should be noted that respondents were not asked about the mode or timing of delivery for 371 
the analgesics given, or the reasons for selection or avoidance of some compounds. This 372 
information would be valuable as it would allow elucidation of various aspects of analgesia 373 
use in cats. This would include the potential to identify if animals would be under full or 374 
partial pain management at various stages of the surgical process.  375 
In conclusion, there is clear evidence of significant improvements in analgesia provision for 376 
cats across the countries surveyed, although more attention to the pain management of 377 
discharged patients may be warranted. The authors identify that much research is still 378 
required to understand the value of pre/intra-operative and multi-modal analgesia use in cats, 379 
especially as it relates to central sensitisation.  380 
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Table 1. Overall number (and percentage) of respondents from New Zealand, Australia and 471 
the UK (total n=717) reporting provision of analgesia at three different time phases (pre/intra-472 
operative, post-operative and post-discharge) to cats undergoing gonadectomy. Variation in 473 
total number is due to missing responses. 474 
Analgesia 
provided 
Pre/intra-operativea post-operativea post-discharge “at home” a 
Castration Spay Castration b Spay Castration b Spay 
Yes 
650/705 
(92.2%) 
624/657 
(95%) 
 327/646 
(50.6%) 
436/651 
(67%) 
24/635 
(3.8%) 
103/641 
(16.1%) 
a  Percentage of practitioners providing analgesia amongst the three time phases is statistically 475 
significantly different for both castration (χ2 = 1045.24; df = 2; p < 0.001) and spaying (χ2 = 476 
853.21; df = 2; p < 0.001). 477 
b Percentage of practitioners providing analgesia for males is statistically significantly 478 
different as compared to females during the post-operative  (χ2  = 30.955; df = 1;  p <  0.001) 479 
and the post-discharge (χ2  = 54.034; df = 1;  p < 0.001) phases.  480 
481 
18 
Table 2: Number (percentage of valid responses) of veterinarians that provide post-operative 482 
analgesia to cats undergoing gonadectomy. Data are presented relative to the respondent’s 483 
country of practice. Differences among the total number of responses and the number of 484 
responses in any category are due to missing datum points for specific questions. 485 
 486 
Country of practice 
Respondents providing post-
operative analgesia for castration 
Respondents providing post-
operative analgesia for spaying 
Yes Yes 
New Zealand  
(n = 249) 
137 (62.6%) 188 (84.3%) 
Australia  
(n = 199) 
115 (65.3%) 137 (76.1%) 
United Kingdom 
(n=269) 
73 (31.0%) 109 (44.3%) 
 487 
 488 
 489 
 490 
 491 
 492 
 493 
 494 
 495 
 496 
 497 
 498 
 499 
 500 
 501 
 502 
 503 
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Table 3. Response of veterinarians (n = 717) to a survey about pain relief for cats undergoing 504 
gonadectomy. Data include those that provide one or more analgesics, based on the reported 505 
class(es) used. Data represent the analgesic classes used either pre/intra-operatively and post-506 
operatively by veterinarians from the UK, New Zealand or Australia. Numbers are presented 507 
as reported use/number of respondents using analgesia (percentage). Variation between 508 
numbers is due to non-report of drugs used. 509 
Time 
Phase 
Analgesia 
New Zealand Australia United Kingdom 
Spay Castration Spay Castration Spay Castration 
Pre/intra-
operativea 
Opioidc only 
171/213 
(80.3) 
162/227 
(71.4) 
98/164 
(59.8) 
97/169 
(57.4) 
57/244 
(23.4) 
61/255 
(23.9) 
NSAIDd only 
13/213 
(6.1) 
13/227 
(5.7) 
29/164 
(17.7) 
31/169 
(18.3) 
108/244 
(44.3) 
109/255 
(42.7)  
Opioid/NSAID  
combination 
5/213 
(2.3) 
5/227 
(2.2) 
19/164 
(11.6) 
13/169 
(7.7) 
66/244 
(27.1) 
55/255 
(21.6) 
Othere only 
5/213 
(2.3) 
8/227 
(3.5) 
5/164  
(3) 
7/169 
(4.1) 
- - 
Opioid/opioid 
combination 
7/213 
(3.2) 
8/227 
(3.5) 
4/164 
(2.4) 
- 
2/244 
(0.8) 
3/255 
(1.2) 
NSAID/NSAID 
combination 
- - - - 
3/244 
(1.2) 
3/255 
(1.2) 
Opioid/other 
combination 
6/213 
(2.8) 
5/227 
(2.2) 
5/164  
(3) 
6/169 
(3.6) 
- - 
NSAID/other 
combination 
- - - 
1/169  
(0.6) 
2/244 
(0.8) 
1/255 
(0.4) 
Other combination - 
2/227 
(0.9) 
1/164 
(0.6) 
3/169 
(1.8) 
- - 
        
Post-
operativeb 
Opioid only 
34/188 
(18.1) 
27/137 
(19.7) 
11/137 
(8) 
6/115 
(5.2) 
12/109 
(11) 
8/109 
(7.3) 
NSAID only 
127/188 
(67.6) 
98/137 
(71.5) 
103/137 
(75.1) 
97/115 
(70.8) 
87/109 
(79.8) 
56/109 
(51.4) 
 
Opioid/NSAID  
combination 
15/188 
(8) 
5/137 
(3.6) 
9/137 
(6.6) 
5/115 
(4.5) 
7/109 
(6.4) 
5/109 
(4.6) 
NSAID/NSAID 
combination 
4/188 
(2.1) 
3/137 
(2.2) 
7/137 
(5.1) 
6/115 
(5.2) 
2/109 
(1.8) 
2/109 
(1.8) 
20 
 
Opioid/Opioid 
combination 
1/188 
(0.5) 
1/137 
(0.7) 
- - - - 
 510 
a Use of drug categories ‘opioid only’ NSAID only’ and ‘opioid/NSAID combination’ differ significantly 511 
amongst countries for  castration and spaying respectively ( χ2 = 171.521; df = 4; p < 0.001;  χ2 = 191.853; df = 512 
4; p < 0.001) 513 
b Use of drug categories ‘opioid only’ NSAID only’ and ‘opioid/NSAID combination’ differ significantly 514 
amongst countries for  castration (χ2 = 13.026; df = 4; p < 0.011) but not for spaying (χ2 = 8.161; df = 4; p = 515 
0.086). 516 
c Opioids in categories include reported use of: Morphine; buprenorphine; butorphanol; methadone; pethidine 517 
d Non-steroidal anti-inflammatory drugs (NSAID) in categories include reported use of: Meloxicam; carprofen; 518 
ketoprofen; tolfenamic acid 519 
e‘Other’ in categories includes reported use of: Medetomidine; Ketamine; acepromazine and other 520 
miscellaneous agents reported fewer than 4 times by the respondents which are neither opioid nor NSAID  521 
  522 
 523 
